Ingredients

Standardized Excipient GMP

March 01, 2012

This article provides guidance for industry on how to comply with the pending American National Standard on excipient GMP, with a focus on risk assessment.

Advances in Taste-masking

March 01, 2012

Taste-masking is an important consideration to ensure patient compliance.

Physical-Chemical Identifiers: A Q&A with FDA on the Final Guidance

March 01, 2012

FDA answers key questions about the October 2011 guidance on using physical–chemical identifiers in solid oral dosage products to help prevent and avoid counterfeiting.

Expanding Capabilities in the Pharmaceutical Cold Chain

February 02, 2012

As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.

Formulation Development Forum: Boronate Cross-linked Micelles

February 02, 2012

A new class of nanoparticles hold promise for preventing premature drug release and offering greater accuracy and effectiveness in drug delivery.

Case Studies in Pharmaceutical Project Management

February 01, 2012

A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories.

Assessing Tablet-Sticking Propensity

January 02, 2012

The authors designed an upper punch with a removable punch tip to determine a tablet formulation's propensity to stick by weighing the mass of powder adhered to the punch tip.

Venture-Capital Funding Falls but Shows Some Momentum

January 02, 2012

Challenges remain, particularly for early-stage biopharmaceutical companies.

Broadening the Toolbox in Drug Development and Analysis

January 02, 2012

Some recent advances involve strategies for accelerating reaction discovery, approaches for inducing chirality and stereochemical analysis, and applications in nanotechnology for protein elucidation.

Antibody-Drug Conjugates: Looking Ahead to an Emerging Class of Biotherapeutic

January 02, 2012

Creating a successful antibody-drug conjugate requires careful selection of the drug, antibody, and linker.